Vir Biotechnology (VIR) EBT (2018 - 2025)
Historic EBT for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$163.0 million.
- Vir Biotechnology's EBT rose 2368.03% to -$163.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$499.4 million, marking a year-over-year increase of 738.19%. This contributed to the annual value of -$523.1 million for FY2024, which is 1672.87% up from last year.
- Vir Biotechnology's EBT amounted to -$163.0 million in Q3 2025, which was up 2368.03% from -$110.8 million recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's EBT registered a high of $921.9 million during Q1 2022, and its lowest value of -$233.7 million during Q2 2022.
- Over the past 5 years, Vir Biotechnology's median EBT value was -$120.9 million (recorded in 2025), while the average stood at -$12.7 million.
- Within the past 5 years, the most significant YoY rise in Vir Biotechnology's EBT was 64642.86% (2022), while the steepest drop was 47778.59% (2022).
- Quarter analysis of 5 years shows Vir Biotechnology's EBT stood at $545.9 million in 2021, then crashed by 127.78% to -$151.6 million in 2022, then grew by 20.36% to -$120.8 million in 2023, then rose by 13.32% to -$104.7 million in 2024, then crashed by 55.69% to -$163.0 million in 2025.
- Its EBT stands at -$163.0 million for Q3 2025, versus -$110.8 million for Q2 2025 and -$120.9 million for Q1 2025.